Study Details

Back
Study ID 5878-CL-0101
Study Title An Open-label Phase 1 Study of Oral ASP5878 at Single and Multiple Doses in Patients with Solid Tumors
Clinicaltrials.gov Identifier NCT02038673
Compound Name ASP5878
Medical Indication or Disease Solid tumors
Study Sponsor Astellas Pharma Inc.
Collaborator Not Applicable
Study Start Date 05-Nov-2013
Study Completion Date 19-Jul-2017
Clinical Study Result
Select the language
English
Plain Language Summary
Select the language
Japanese

QUICK SEARCH

USEFUL LINKS